We are live on ! Find out more
Jacobs Levy Equity Management

Jacobs Levy Equity Management Portfolio holdings

AUM $23.8B
1-Year Est. Return 25.4%
This Fund
S&P 500
This Quarter Est. Return
+8.27%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$5.6B
AUM Growth
+$769M
Cap. Flow
+$469M
Cap. Flow %
8.38%
Top 10 Hldgs %
13.16%
Holding
1,266
New
125
Increased
352
Reduced
429
Closed
264

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$58.9M
2
EOG icon
EOG Resources
EOG
+$37.7M
3
YUM icon
Yum! Brands
YUM
+$29.2M
4
A icon
Agilent Technologies
A
+$25.5M
5
OXY icon
Occidental Petroleum
OXY
+$24.6M

Top Sells

Rank Stock Value
1
GEN icon
Gen Digital
GEN
+$27.1M
2
ICE icon
Intercontinental Exchange
ICE
+$26M
3
GPN icon
Global Payments
GPN
+$24.2M
4
CDNS icon
Cadence Design Systems
CDNS
+$22.8M
5
AAPL icon
Apple
AAPL
+$22.7M

Sector Composition

Rank Sector Weight
1 Technology 19.55%
2 Financials 15.15%
3 Healthcare 14.96%
4 Consumer Discretionary 10.52%
5 Industrials 10.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VXRT
926
DELISTED
Vaxart
VXRT
$172K ﹤0.01%
8,127
-850
-9% -$13.4K
IVAC
927
DELISTED
Intevac Inc
IVAC
$172K ﹤0.01%
29,119
-2,800
-9% -$16.7K
MPG
928
DELISTED
Metaldyne Performance Group Inc.
MPG
$172K ﹤0.01%
10,875
-7,725
-42% -$121K
ASYS icon
929
Amtech Systems
ASYS
$278M
$167K ﹤0.01%
33,634
– –
FRO icon
930
Frontline
FRO
$8.75B
$167K ﹤0.01%
23,300
– –
LCUT icon
931
Lifetime Brands
LCUT
$199M
$165K ﹤0.01%
12,278
– –
BFYT
932
DELISTED
Benefytt Technologies, Inc. Class A Common Stock
BFYT
$160K ﹤0.01%
30,526
– –
GALT icon
933
Galectin Therapeutics
GALT
$229M
$158K ﹤0.01%
139,714
-48,193
-26% -$85.7K
FF icon
934
Future Fuel
FF
$204M
$156K ﹤0.01%
+13,810
New +$157K
ECYT
935
DELISTED
Endocyte, Inc. Common Stock
ECYT
$154K ﹤0.01%
49,754
-17,739
-26% -$55.3K
APPS icon
936
Digital Turbine
APPS
$1.02B
$150K ﹤0.01%
143,272
+38,100
+36% +$44.2K
RESI
937
DELISTED
Front Yard Residential Corporation Common Stock
RESI
$150K ﹤0.01%
13,800
-14,400
-51% -$145K
LEAF
938
DELISTED
Leaf Group Ltd.
LEAF
$149K ﹤0.01%
26,136
– –
CDXS icon
939
Codexis
CDXS
$135M
$148K ﹤0.01%
33,329
+16,700
+100% +$70.1K
FRTX
940
DELISTED
Fresh Tracks Therapeutics, Inc. Common Stock
FRTX
$144K ﹤0.01%
151
– –
CGRN
941
DELISTED
Capstone Green Energy Corporation Common Stock
CGRN
$144K ﹤0.01%
10,500
– –
SREV
942
DELISTED
ServiceSource International, Inc.
SREV
$144K ﹤0.01%
29,500
– –
DRH icon
943
Diamondrock Hospitality Co
DRH
$2.63B
$142K ﹤0.01%
15,650
-12,400
-44% -$121K
MTEM
944
DELISTED
Molecular Templates, Inc.
MTEM
$142K ﹤0.01%
+1,270
New +$174K
HWCC
945
DELISTED
Houston Wire & Cable Company
HWCC
$136K ﹤0.01%
21,914
-12,469
-36% -$72.1K
JNP
946
DELISTED
Juniper Pharmaceuticals, Inc. Common Stock
JNP
$136K ﹤0.01%
24,590
-400
-2% -$2.65K
NL icon
947
NLI Holdings
NL
$284M
$135K ﹤0.01%
34,405
– –
XRX icon
948
Xerox
XRX
$337M
$133K ﹤0.01%
+4,971
New +$128K
TBHC
949
DELISTED
The Brand House Collective
TBHC
$130K ﹤0.01%
+10,639
New +$149K
LPG icon
950
Dorian LPG
LPG
$1.94B
$129K ﹤0.01%
21,556
-171,280
-89% -$1.06M
36 37
38
39 40

Similar funds

Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Teacher Retirement System of Texas
Teacher Retirement System of Texas Austin, Texas $24B AUM 29.51% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return
CHP
Castle Hook Partners New York $23.4B AUM 158.96% 1-Year Est. Return
SAM
SEB Asset Management Stockholm $23.4B AUM
JG
Jain Global New York $24.2B AUM 34.82% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Jacobs Levy Equity Management's Q3 2016 Portfolio in Review

As of Q3 2016, Jacobs Levy Equity Management held 1,266 positions worth $5.6B, up 16% from $4.83B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Jacobs Levy Equity Management deployed $469M of net new capital in Q3 2016, opening 125 new positions and adding to 352 existing holdings. Its largest new stake was Bristol-Myers Squibb: 916,932 shares worth $49.4M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Intercontinental Exchange, an estimated $26M trimmed.

  • Jacobs Levy Equity Management's largest Q3 2016 buy was Bristol-Myers Squibb: 916,932 shares worth $49.4M.
  • Jacobs Levy Equity Management added most to Agilent Technologies in Q3 2016, an estimated $25.5M increase.
  • Jacobs Levy Equity Management's biggest Q3 2016 reduction was Intercontinental Exchange, cutting an estimated $26M.
  • Jacobs Levy Equity Management fully exited Gen Digital in Q3 2016, selling an estimated $27.1M.
  • Jacobs Levy Equity Management's ten largest holdings make up 13% of its $5.6B portfolio in Q3 2016.
  • Jacobs Levy Equity Management opened 125 new positions and closed 264 in Q3 2016.
  • Jacobs Levy Equity Management's portfolio value rose 16% quarter-over-quarter to $5.6B.

Based on Jacobs Levy Equity Management's 13F filing for Q3 2016, filed 14 Nov 2016.